The second divergently transcribed operon encodes the paralogs FolEIB, PyrC2, AmiA, and a -class carbonic anhydrase
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
Maryland Trim Clinic (MTC) in Laurel, MD Navigating the intersection of metabolic health, peptide therapy, and longevity requires precision, not guesswork
The breadth of DSIPs biological activity spanning sleep regulation, stress modulation, pain processing, antioxidant defence, and neuroprotection has led some researchers to characterise it as an adaptogenic peptide: one that supports homeostatic balance across multiple physiological systems rather than acting on a single discrete target